The outlook of companies tied to blockbuster drugs like Viagra presents a complex investment scenario . While the initial rise of copyright, fueled by Viagra's unprecedented popularity, generated substantial profits , the expiry in key territories has introduced considerable uncertainty . Investors are now grappling with the effect of rival medicat